<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-156669</identifier>
<setSpec>1138-3593</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Outcomes evaluation after the implementation of a pre-hospital thrombolysis protocol in rural areas</dc:title>
<dc:description xml:lang="en">Introduction. The aim is to evaluate the outcomes obtained from the implementation of a pre-hospital thrombolysis protocol in 3 rural emergency care teams, as well as delays and strategies of reperfusion applied in the treatment of the ST-segment elevation myocardial infarction. Material and methods. Retrospective cohort study (n=52) with historical control (n=20) of the patients assisted for ST-segment elevation myocardial infarction. Medical emergency care teams, hospital, computerized medical history and ARIAM register reports were revised, obtaining epidemiological and clinical features, off-hospital management, reperfusion, time intervals and mortality. Results. The baseline features in both groups were not significantly different. There was a non-significant improvement of emergency care teams-hospital diagnostic concordance (85.3 versus 76.9%). We found a similar use of nitroglycerin, morphine and aspirin; significant increase (P&lt;0.0001) of clopidogrel/prasugrel (55 versus 90.4%) and enoxaparin/fondaparinux (35 versus 76.9%), as well as pre-hospital thrombolysis (5 versus 30,8%, P&lt;0.03), that was applied within the first 2h to 71.4%, with a median door-needle of 40min, whereas in-hospital thrombolysis and primary angioplasty were performed after 3h from the symptoms onset (P&lt;0.01). Delays are associated with the patient's own lateness (P&lt;0.02). Pharmaco-invasive strategy increases (62.5 versus 84.6%) more than primary angioplasty (15 versus 17.3%), reducing in-hospital thrombolysis (35 versus 19.2%), all of them non-significant. Complications are similar and one-year mortality is reduced (P&lt;0.67). Conclusions. The protocol is effective, safe, and reliable. It reduces delays and improves pre-hospital attention. The pharmaco-invasive strategy is a valid option (AU)</dc:description>
<dc:creator>Hernández-García, J</dc:creator>
<dc:creator>Giménez-Ruiz, JJ</dc:creator>
<dc:creator>Dueñas-Jurado, JM</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Introducción. El objetivo es evaluar los resultados del protocolo en 3 dispositivos móviles de cuidados críticos y urgencias rurales, así como los retrasos y estrategias de reperfusión empleadas en el síndrome coronario agudo con elevación del segmento ST. Material y métodos. Estudio de cohortes retrospectivo (n=52) con control histórico (n=20) de los síndromes coronarios agudos con elevación del segmento ST atendidos. Se revisaron los informes de los dispositivos móviles de cuidados críticos y urgencias y de alta hospitalaria, la historia informatizada y el registro ARIAM, recogiendo características epidemiológicas y clínicas, datos de la asistencia, reperfusión, intervalos temporales y mortalidad. Resultados. Las características de ambos grupos no difieren significativamente. Aumentó la concordancia diagnóstica de los dispositivos móviles de cuidados críticos y urgencias-hospital (85,3 versus 76,9%), sin significación estadística. Hubo un uso similar de nitroglicerina, mórficos y AAS; aumento significativo (p&lt;0,0001) de clopidogrel/prasugrel (55 versus 90,4%) y enoxaparina/fondaparinux (35 versus 76,9%), así como de fibrinólisis prehospitalaria (5 versus 30,8%, p&lt;0,03), que se aplica en&lt;2h al 71,4%, con un tiempo puerta-aguja de 40min, mientras la fibrinólisis hospitalaria y la angioplastia primaria se realizan a partir de la tercera hora (p&lt;0,01). Los retrasos se asocian a la demora del paciente (p&lt;0,02). Aumenta más la estrategia farmacoinvasiva (62,5 versus 84,6%) que la angioplastia primaria (15 versus 17,3%), disminuyendo la fibrinólisis hospitalaria (35 versus 19,2%), todas ellas sin significación estadística. Las complicaciones son similares, disminuyendo la mortalidad al año (p&lt;0,67). Conclusiones. El protocolo es efectivo, seguro, fiable, reduce las demoras y mejora la atención prehospitalaria. La estrategia farmacoinvasiva es una opción válida (AU)</dc:description>
<dc:source>SEMERGEN, Soc. Esp. Med. Rural Gen. (Ed. Impr.);42(7): 440-448, oct. 2016. tab, graf</dc:source>
<dc:identifier>ibc-156669</dc:identifier>
<dc:title xml:lang="es">Evaluación de resultados tras la implantación de un protocolo de fibrinólisis extrahospitalaria en zonas rurales</dc:title>
<dc:subject>^d28621</dc:subject>
<dc:subject>^d10221^s22074</dc:subject>
<dc:subject>^d28611</dc:subject>
<dc:subject>^d52613^s22054</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d35170^s22045</dc:subject>
<dc:subject>^d35251</dc:subject>
<dc:subject>^d3439^s22074</dc:subject>
<dc:subject>^d25658</dc:subject>
<dc:subject>^d28457^s22048</dc:subject>
<dc:subject>^d55440</dc:subject>
<dc:subject>^d10221^s22049</dc:subject>
<dc:subject>^d10221^s22048</dc:subject>
<dc:subject>^d28379^s22045</dc:subject>
<dc:subject>^d52613^s22080</dc:subject>
<dc:subject>^d28457^s22066</dc:subject>
<dc:subject>^d11756^s22045</dc:subject>
<dc:subject>^d5453^s22031</dc:subject>
<dc:type>article</dc:type>
<dc:date>201610</dc:date>
</metadata>
</record>
</ibecs-document>
